Meta-analysis of 9 studies (295 women with early-stage endometrioid endometrial carcinoma given fertility-sparing treatment): pooled complete response was 95% POLE-mutated, 82% NSMP, 62% MMRd and 41% p53-abnormal; progression 2%, 3%, 14% and 38%.
Meta-analysisn = 295
Raffone et al. Molecular groups predict response to fertility-sparing treatment of endometrial carcinoma: a systematic review and metanalysis